Pure Global

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis - Trial NCT06231264

Access comprehensive clinical trial information for NCT06231264 through Pure Global AI's free database. This phase not specified trial is sponsored by Xijing Hospital and is currently Recruiting. The study focuses on Ulcerative Colitis. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06231264
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06231264
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
A Multicenter Randomized Controlled Trial of Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Study Focus

Ulcerative Colitis

transcutaneous electrical acustimulation at treatment sites

Interventional

device

Sponsor & Location

Xijing Hospital

Xi'an,Xi'an,Xi'an,Xi'an, China

Timeline & Enrollment

N/A

Jan 19, 2024

Mar 01, 2025

96 participants

Primary Outcome

Clinical response

Summary

The aim of this study was to evaluate the efficacy and safety of transcutaneous electrical
 acustimulation in patients with mild to moderate ulcerative colitis.

ICD-10 Classifications

Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis

Data Source

ClinicalTrials.gov

NCT06231264

Device Trial